by Danny KEMP THE HAGUE, Netherlands (AFP) — The EU’s drug regulator will decide Monday whether to approve a Covid jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy. Novavax’s jab, a protein-based vaccine of the kind used around the world to protect against many childhood illnesses, would be the fifth coronavirus shot authorized for the European Union. Approval would also be a boost for […]